Source:http://linkedlifedata.com/resource/pubmed/id/11200267
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10-12
|
pubmed:dateCreated |
2001-1-25
|
pubmed:abstractText |
The CXC chemokine receptor CXCR4 is used as a major co-receptor for fusion and entry by syncytia-inducing T-tropic (X4) isolates of HIV-1. In the present study, we report the effects of an antisense oligodeoxyribonucleotide on the inhibition of CXCR4 gene expression in X4 HIV-1 infected HeLa-CD4 cells, to find more efficacious therapeutic possibilities for Human Immunodeficiency Virus type 1 (HIV-1) infection. Antisense phosphorothioate oligodeoxyribonucleotides (anti-S-ODNs) corresponding to the sequence of bases 69 to 88 of the human CXCR4 mRNA gene were synthesized. When the naked anti-S-ODN was incubated with HeLa-CD4 cells, the surface levels of this chemokine receptor were reduced up to 50%, indicating sequence-specific inhibition. We also examined the concomitant use of a basic peptide transfection reagent, nucleosomal histone proteins (RNP), for delivery of anti-S-ODNs. The anti-S-ODN encapsulated with RNP had higher inhibitory effects on p24 products than the naked anti-S-ODN.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1525-7770
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1709-19
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11200267-Base Sequence,
pubmed-meshheading:11200267-HeLa Cells,
pubmed-meshheading:11200267-Humans,
pubmed-meshheading:11200267-Oligonucleotides, Antisense,
pubmed-meshheading:11200267-Organophosphorus Compounds,
pubmed-meshheading:11200267-Receptors, CXCR4,
pubmed-meshheading:11200267-Thionucleotides
|
pubmed:articleTitle |
Antisense phosphorothioate oligonucleotides targeted to the human chemokine receptor CXCR4.
|
pubmed:affiliation |
Department of Industrial Chemistry, Chiba Institute of Technology, Narashino, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|